Back
Genmab AS Vs. Evaxion Biotech AS Industry Stock Comparison
Sell
19
GMAB
Genmab AS
Last Price:
$20.31
Seasonality Move:
3.07%
Sell
5
EVAX
Evaxion Biotech AS
Last Price:
$0.90
Seasonality Move:
-43.46%
Sell
5
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
-
The current Evaxion Biotech AS [EVAX] share price is $0.92. The Score for EVAX is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GMAB Stock Price Chart
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $0.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight buying pressure.
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 36.61 | Sell |
Chaikin Money Flow: | 304947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.25 - 21.61) | Sell |
Bollinger Bands (100): | (21.47 - 26.57) | Sell |
EVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 22.46 | Sell |
Chaikin Money Flow: | -5392 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.1 - 1.56) | Sell |
Bollinger Bands (100): | (1.75 - 3.19) | Sell |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.37 | Sell |
20-day SMA: | 21.02 | Sell |
50-day SMA: | 21.85 | Sell |
200-day SMA: | 26.17 | Sell |
8-day EMA: | 20.44 | Sell |
20-day EMA: | 20.92 | Sell |
50-day EMA: | 21.95 | Sell |
200-day EMA: | 25.7 | Sell |
EVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.04 | Sell |
20-day SMA: | 1.3 | Sell |
50-day SMA: | 1.95 | Sell |
200-day SMA: | 2.95 | Sell |
8-day EMA: | 1.03 | Sell |
20-day EMA: | 1.29 | Sell |
50-day EMA: | 1.8 | Sell |
200-day EMA: | 3.44 | Sell |
Genmab AS Earnings Growth & GMAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.28 per share.
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.57 per share, and an increase next year of $0.05 per share.
Genmab AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Evaxion Biotech AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |